| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 19 | 36 |
| Expenses | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 18 | 34 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 2 |
| Operating Profit % | 0 % | 4 % | 1 % | 0 % | 0 % | 0 % | -982 % | -200 % | -217 % | 1 % | 6 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 3 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 | 2 |
| EPS in ₹ | -0.01 | 4.70 | 0.02 | -0.03 | -0.01 | 0.00 | -0.12 | 0.00 | 0.05 | 0.09 | 1.13 | 1.24 |
Gujarat Inject Kerala
Gujarat Inject Kerala
13.85
+0.40
(2.97%)
Market Cap
202.86 Cr
PE Ratio
112.08
Volume
5,15,813.00
Day High - Low
13.90 - 13.45
52W High-Low
14.30 - 1.90
There are new updates from the company21 hrs ago
View
Key Fundamentals
Market Cap
202.86 Cr
EPS
1.24
PE Ratio
112.08
PB Ratio
16.64
Book Value
0.81
EBITDA
2.31
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
10.16
Debt to Equity
0.00
Actual
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,952.00 | #1 4,68,350.19 | 40.45 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 68.08 | |
7,270.50 | 1,93,008.93 | 74.28 | 10,560.00 | 8.73 | 2,520 | 13.44 | 71.13 | |
5,005.00 | 1,69,391.94 | 78.68 | 13,886.20 | 20.34 | 2,138 | -26.91 | 78.96 | |
1,161.90 | 1,16,914.33 | 22.08 | 27,657.90 | 17.64 | 5,026 | 7.82 | 58.78 | |
1,439.70 | 1,16,305.49 | 30.10 | 29,044.60 | 2.24 | 3,870 | -55.32 | 55.29 | |
2,499.00 | 1,14,262.41 | #1 21.08 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 62.48 | |
2,590.40 | 1,06,982.48 | 53.92 | 14,277.60 | 12.03 | 1,750 | 31.75 | 58.13 | |
1,230.90 | 1,02,739.42 | 25.01 | 35,058.60 | 3.90 | 4,158 | -86.05 | 37.29 | |
1,553.90 | 89,407.97 | 25.75 | 33,384.70 | 3.21 | 3,376 | 1.99 | 54.61 | |
1,556.20 | 84,012.48 | 94.65 | 6,867.80 | #1 22.01 | 890 | 21.18 | 67.15 |
Growth Rate
Revenue Growth
89.17 %
Net Income Growth
81.00 %
Cash Flow Change
74.30 %
ROE
947.42 %
ROCE
911.29 %
EBITDA Margin (Avg.)
-3.06 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 37 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 10 | 12 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 0 |
| Total Equity & Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 12 | 37 |
| Current Liabilities | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 25 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 9 | 10 | 12 |
| Reserve & Surplus | -8 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -3 | -5 | -3 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 11 | 15 | 15 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | -3 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -6 | -2 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | -2 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 81.40 % | 80.97 % | 81.10 % | 81.09 % | 81.04 % | 80.92 % | 80.77 % | 81.73 % | 87.18 % | 87.18 % | 87.34 % | 86.70 % | 88.24 % | 86.82 % | 86.79 % | 86.80 % | 85.91 % | 83.95 % | 83.95 % | 92.83 % | 90.02 % | 88.55 % |
| Others | 18.60 % | 19.02 % | 18.90 % | 18.91 % | 18.95 % | 19.08 % | 19.23 % | 18.26 % | 12.82 % | 12.82 % | 12.66 % | 13.30 % | 11.75 % | 13.18 % | 13.21 % | 13.20 % | 14.08 % | 16.05 % | 16.05 % | 7.17 % | 9.98 % | 11.45 % |
| No of Share Holders | 6,367 | 6,365 | 6,364 | 6,365 | 6,366 | 6,353 | 6,333 | 6,341 | 6,551 | 6,551 | 6,633 | 6,775 | 6,721 | 6,706 | 6,698 | 6,627 | 6,773 | 7,303 | 7,303 | 8,151 | 7,826 | 7,853 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Jan 2024 |  Extraordinary General Meeting | NA | 20 Jan 2024 | 1.30 | 1.43 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 1.86 | 1.86 |
| 22 Oct 2024 |  Quarterly Result Announcement | NA | 22 Oct 2024 | 1.86 | 1.77 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 2.60 | 2.60 |
| 18 Feb 2025 |  Change Of Name | NA | 18 Feb 2025 | 2.67 | 2.67 |
| 03 Apr 2025 | Extraordinary General Meeting | NA | 03 Apr 2025 | 2.60 | 2.60 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1.93 | 2.00 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 2.10 | 2.13 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 2.01 | 2.00 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 2.54 | 2.60 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 5.45 | 5.76 |
| 20 May 2026 | Quarterly Result Announcement | NA | 20 May 2026 | 10.48 | 10.29 |
| 18 Feb 2025 |  Split | 1:10 | 08 Jul 2026 | 2.67 | 2.67 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
21 mins ago
21 mins agoBoard Meeting Outcome for OUTCOME OF BOARD MEETING3 hrs ago
3 hrs agoUNAUDITED FINANCIAL RESULTS - 30.06.20263 hrs ago
3 hrs agoAnnouncement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association21 hrs ago
21 hrs agoBoard Meeting Intimation for Consideration And Approval Of Financial Results.4 days ago
4 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
8 days agoClosure of Trading WindowJun 30, 2026
Jun 30, 2026Corporate Action-updates on Outcome of Sub division / Stock SplitJun 29, 2026
Jun 29, 2026Corporate Action-Outcome of Sub division / Stock SplitJun 27, 2026
Jun 27, 2026Announcement under Regulation 30 (LODR)-CessationJun 24, 2026
Jun 24, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJun 11, 2026
Jun 11, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 25, 2026
May 25, 2026Results - Financial Results For 31/03/2026May 20, 2026
May 20, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 20Th May 2026 And Submission Of Audited Financial Results (Standalone) For The Fourth Quarter And Year Ended On 31St March 2026May 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Resignation of Chairman and Managing DirectorMay 16, 2026
May 16, 2026Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For The Quarter & Year Ended 31St March 2026.May 15, 2026
May 15, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 16, 2026
Mar 16, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 16, 2026
Mar 16, 2026Results - Financial Results For The Quarter Ended On 31/12/2025Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday 14Th February 2026 And Submission Of Un-Audited Financial Results (Standalone) For The Third Quarter And Nine Months Ended On 31St December 2025.Feb 14, 2026
Feb 14, 2026Board Meeting Intimation for Gujarat Inject (Kerala) Limited Scheduled To Be Held On Saturday 14Th February 2026 For Consideration & Approval Of
Un-Audited Financial Results For The Third Quarter And Nine Months Ended On 31St December 2025
Feb 11, 2026
Feb 11, 2026Closure of Trading WindowDec 31, 2025
Dec 31, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 13, 2025
Dec 13, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 09, 2025
Dec 09, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025Nov 13, 2025
Nov 13, 2025UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025. Nov 13, 2025
Nov 13, 2025Board Meeting Intimation for Un-Audited Financial Results (Standalone) Of The Company For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report Of The Statutory Auditors Thereon;Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated Thursday 30Th October 2025Oct 30, 2025
Oct 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 03, 2025
Oct 03, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Reg. 34 (1) Annual Report.Sep 10, 2025
Sep 10, 2025Notice Of 34Th Annual General Meeting Along With Annual Report Of The Company For F.Y. 2024-25.Sep 10, 2025
Sep 10, 2025Board Meeting Outcome for Change Of Object Of The Company.Sep 08, 2025
Sep 08, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 14Th August 2025Aug 14, 2025
Aug 14, 2025FINANCIAL RESULTS 30.06.2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June 2025Aug 11, 2025
Aug 11, 2025Revised Outcome Of The Board Meeting Held On 07Th July 2025Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-CessationJul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 07, 2025
Jul 07, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 07Th July 2025Jul 07, 2025
Jul 07, 2025Technical Indicators
RSI(14)
Neutral 64.28
ATR(14)
Volatile 0.67
STOCH(9,6)
Neutral 65.36
STOCH RSI(14)
Neutral 68.27
MACD(12,26)
Bullish 0.03
ADX(14)
Strong Trend 48.05
UO(9)
Bearish 32.91
ROC(12)
Uptrend And Accelerating 9.35
WillR(14)
Neutral -32.69
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
